Jennifer Yull
Primary Podiatric Medicine · Colorado Springs, CONPI 1548240609
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (46.4%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by Treace Medical Concepts, Inc. at 50.1% of the total. Reporting peaked in 2023 at $780 and has fallen 84.2% since, to $123 in 2025.
Across 18 payments — averaging $81.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Treace Medical Concepts, Inc.$734
- Johnson & Johnson$211
- Organogenesis Inc.$148
- Convatec Inc.$141
- Alliance Medical$123
- Stryker$59
- plus $51 from 1 others
What the payments were for
- Speaking & faculty fees$1279%
- Travel & lodging$68146%
- Food & beverage$65845%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Treace Medical Concepts, Inc. | 4 | $734 |
| Johnson & Johnson | 5 | $211 |
| Organogenesis Inc. | 2 | $148 |
| Convatec Inc. | 1 | $141 |
| Alliance Medical | 1 | $123 |
| Stryker | 3 | $59 |
| Amgen | 2 | $51 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lapiplasty System$654
- MOTOBAND$143
- InnovaMatrix AC$141
- Apligraf$127
- Dermagraft$127
- Puraply/Affinity/NuTech$127
How this compares
Too few primary podiatric medicine providers in Coloradoto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Terbinafine Hcl | 24 | $506 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 27 | $411 |
| Gabapentin | 11 | $188 |
| Cephalexin | 28 | $157 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 11 | $106 |
Paid to pharmacies, not to this prescriber.
Other primary podiatric medicine in Colorado Springs
- Kristen TrelevenGreeley$7K
- Hani SaeedDenver$2K
- Kevin DericksonDenver$2K
- Frederick MechanikDenver$1K
- Michael ThomasFort Collins$669
- Garrett MooreDenver$410
- Stephen AlbertDenver$76
- Edward RaczkaDenver$67
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.